(        10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270        )
	|         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |         |
AGPAT2 human	MELWPCLAAALLLLLLLVQLSRAAEFYAKVALYCALCFTVSAVASLVCLLRHGGRTVENMSIIGWFVRSFkyFyGLRFEVRDPRRLQEARPCVIVSNHQSILDMMGLMEVLPERCVQIAKRELLFLGPVGLIMYLGGVFFINRQRSSTAMTVMADLGERMVRENLkVWIYPEGTRNDNGDLLPFkKGAFYLAVQAQVPIVPVVYSSFSSFYNTKKKFFTsGTVTVQVLEAIPtsGLtAADVPALVDTCHRAMRTTFLHISktPQENGATAGsGVQPAQ
AGPAT2 mouse	MDPWPWLTAALLLLLLLVQLSRTARFYAKVGLYCVLCLSFSAAASIVCLLRHGGRTVDNMSIISWFVRSFKYVYGLRFEVSGQkkLEVDGPCVIISNHQSILDMMGLMEILPKRCVQIAkRELMFTGPVGLIMYLGGVYFINRQQARTAMSVMADLGDLMVKENLkVWIYPEGTRNDNGDLLPFkKGAFYLAIQAQVPIIPVVYSSFSSFYNVKTkLFTSGTIKVQVLDAVPTNGLTDADVTKLVDTCyQSMRAtFLQIsQIPQENSAIkEPGVLPAQ
AGPAT2 rat	MDPWPWLTAALLLLLLLVQLNRTARFYVKVGLYCVLCLSFSAAASIVCLLRHGGRTVDNMSIISWFVRSFKYVYGLRFEVSGQKKLEVDGPCVIISNHQSILDMMGLMEILPKRCVQIAKRELMFTGPVGLIMYLGGVYFINRQQAKTAMSLMADLGDLMVKENLKVWIYPEGTRNDNGDLLPFKKGAFYLAIQAQVPIIPVVYSSFSSFYNVKTKLFTSGTIRVQVLDAVPTNGLTDADVTKLVDTCYQSMRATFLQISEIPQENSTIKESGVLPAQ
	*::**:*:************:*:*:**:**:***:**:::**:**:***********:*****:********:*******:::::*::::****:**************:**:**********:*:************:*****::.***::*****::**:******************************:******:************:*:*:*****:.****:*:**:***:***::*****:::**:***:**.:****::::::**:***
Consensus	MDPWPWLTAALLLLLLLVQLSRTARFYAKVGLYCVLCLSFSAAASIVCLLRHGGRTVDNMSIISWFVRSFKYVYGLRFEVSGQKKLEVDGPCVIISNHQSILDMMGLMEILPKRCVQIAKRELMFTGPVGLIMYLGGVYFINRQQARTAMSVMADLGDLMVKENLKVWIYPEGTRNDNGDLLPFKKGAFYLAIQAQVPIIPVVYSSFSSFYNVKTKLFTSGTIRVQVLDAVPTNGLTDADVTKLVDTCYQSMRATFLQISQIPQENSAIKESGVLPAQ